Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation-Reference-Cited by-同舟云学术

Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation

Published:2018-10-31 Issue:11 Volume:15 Page:e1800289
ISSN:1612-1872
Container-title:Chemistry & Biodiversity
language:en
Short-container-title:C&B

Author:

Han Hong-Wei¹²,Lin Hong-Yan¹²,He De-Liu¹²,Ren Yao³,Sun Wen-Xue¹²,Liang Li¹²,Du Mei-Hang¹²,Li Deng-Chao¹,Chu Yi-Chun¹,Yang Min-Kai¹²,Wang Xiao-Ming¹²,Yang Yong-Hua¹²

Affiliation:

1. State Key Laboratory of Pharmaceutical Biotechnology; Nanjing University; Nanjing 210023 P. R. China

2. Co-Innovation Center for Sustainable Forestry in Southern China; Nanjing Forestry University; Nanjing 210037 P. R. China

3. School of Chemistry and Chemical Engineering; Nanjing University; Nanjing 210023 P. R. China

Funder

Program for Changjiang Scholars and Innovative Research Team in University

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbdv.201800289/fullpdf

Reference31 articles.

1. Pharmacol. Res 2009 59

2. Cell Prolif 2012 45

3. Cancer Prev. Res 2014 7

4. Cell Prolif 2014 47

5. Bioorg. Med. Chem 2011 19

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual inhibition of topoisomerase II and microtubule of podophyllotoxin derivative 5p overcomes cancer multidrug resistance;European Journal of Pharmacology;2024-11

2. Reversal of the tamoxifen‑resistant breast cancer malignant phenotype by proliferation inhibition with bromosulfonamidine amino‑podophyllotoxin;Oncology Letters;2024-06-13

3. Podophyllotoxin: Recent Advances in the Development of Hybridization Strategies to Enhance Its Antitumoral Profile;Pharmaceutics;2023-12-04

4. Podophyllotoxin derivatives targeting tubulin: An update (2017–2022);Drug Discovery Today;2023-08

5. Research status of indole-modified natural products;RSC Medicinal Chemistry;2023